Cargando…
The Qi-Bang-Yi-Shen formula ameliorates renal dysfunction and fibrosis in rats with diabetic kidney disease via regulating PI3K/AKT, ERK and PPARγ signaling pathways
Diabetic kidney disease (DKD) is the leading cause of chronic kidney disease (CKD) and a growing public health problem worldwide. Losartan potassium (Los), an angiotensin II receptor blocker, has been used to treat DKD clinically. Recently, multi-herbal formula has been shown to exhibit therapeutic...
Autores principales: | Wang, Zhi, Jian, Guihua, Chen, Teng, Chen, Yiping, Li, Junhui, Wang, Niansong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300429/ https://www.ncbi.nlm.nih.gov/pubmed/36856315 http://dx.doi.org/10.4081/ejh.2023.3648 |
Ejemplares similares
-
Cardioprotection against ischemia/reperfusion injury by QiShenYiQi Pill(®) via ameliorate of multiple mitochondrial dysfunctions
por: Chen, Jing Rui, et al.
Publicado: (2015) -
Effect and Mechanism of QiShenYiQi Pill on Experimental Autoimmune Myocarditis Rats
por: Lv, Shichao, et al.
Publicado: (2016) -
QiShenYiQi pill improves the reparative myocardial fibrosis by regulating autophagy
por: Lv, Shichao, et al.
Publicado: (2020) -
QiShenYiQi Attenuates Renal Interstitial Fibrosis by Blocking the Activation of β-Catenin
por: Zhou, Zhanmei, et al.
Publicado: (2016) -
QiShenYiQi pill for myocardial collagen metabolism and apoptosis in rats of autoimmune cardiomyopathy
por: Lv, Shichao, et al.
Publicado: (2022)